Story

Goldman Sachs Executives Accused of Fraud by Brazilian Police Over Oncoclinicas Tender Offer

ENTHMSVIIDZHZH-TWJAKOHI
Aug 11, 20261 min read
Goldman Sachs Executives Accused of Fraud by Brazilian Police Over Oncoclinicas Tender Offer
Text size
Background

Sao Paulo civil police have formally accused two Goldman Sachs representatives of fraud in a dispute over a mandatory public share tender offer for cancer treatment group Oncoclinicas. According to a police document seen by Reuters, the executives allegedly manipulated corporate information and transactions to avoid the offer, causing financial losses for minority shareholders.

Details of the Allegations

The police filing claims the executives engaged in a scheme to prevent a tender offer demanded by the company's minority investors. The accusations state the representatives allegedly:

  • Concealed ownership details in public documents.
  • Executed share transactions specifically structured to avoid triggering a mandatory tender offer.
  • Revised information previously submitted to regulators to argue that the offer was not legally required.

According to the document, this was done to "convince Oncoclinicas, the CVM (Brazil’s securities regulator), B3 (the stock exchange), and shareholders that the tender offer was not required," ultimately blocking it.

Sample IUX Markets – In-articleAd

Goldman Sachs Responds

Goldman Sachs has refuted the claims, stating the allegations were "unfounded." In a formal statement, the investment bank added, "We continue to believe that we acted appropriately."

Oncoclinicas, the subject of the tender offer dispute, declined to comment. Following the news, shares of Oncoclinicas (B3: ONCO3) fell sharply, ending the trading session down 9.68%.

Read next

More on Stocks
Back to latest news

LATEST